Gastrointestinal Manifestations of STAT3-Deficient Hyper-IgE Syndrome

Journal of Clinical Immunology

Volumn 37, Issue 7, 2017, Pages 695-700

  Arora, Manish ^a   Bagi, Preet ^a   Strongin, Anna ^a   Heimall, Jennifer ^b   Zhao, Xiongce ^a   Lawrence, Monica G ^b   Trivedi, Apurva ^a   Henderson, Carolyn ^b   Hsu, Amy ^b   Quezado, Martha ^c   Kleiner, David E ^c   Venkatesan, Aradhana M ^d   Holland, Steven M ^b   Freeman, Alexandra F ^b   Heller, Theo ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Autosomal dominant hyper immunoglobulin E syndrome; eosinophilic esophagitis; gastrointestinal dysmotility; STAT3

Indexed keywords

STAT3 PROTEIN; IMMUNOGLOBULIN E; STAT3 PROTEIN, HUMAN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL DOMINANT HYPER IMMUNOGLOBULIN E SYNDROME; CHILD; COLON PERFORATION; DIFFUSE ESOPHAGEAL WALL THICKENING; DYSPHAGIA; ENDOSCOPY; ESOPHAGEAL TORTUOSITY; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS DISEASE; ESOPHAGUS STENOSIS; ESOPHAGUS ULCER; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HIATUS HERNIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPER IGE SYNDROME; LABORATORY TEST; LOWER GASTROINTESTINAL TRACT; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MOLECULAR DIAGNOSIS; PATHOLOGY; PRIORITY JOURNAL; STOMACH ULCER; UPPER GASTROINTESTINAL TRACT; BIOPSY; BLOOD; COLONOSCOPY; COMPLICATION; DEFICIENCY; DIAGNOSTIC IMAGING; ECHOGRAPHY; EOSINOPHIL; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRACT; IMMUNOLOGY; LEUKOCYTE COUNT; MIDDLE AGED; PRESCHOOL CHILD; QUESTIONNAIRE; SURGERY; X-RAY COMPUTED TOMOGRAPHY; YOUNG ADULT;

ADOLESCENT; ADULT; BIOPSY; CHILD; CHILD, PRESCHOOL; COLONOSCOPY; EOSINOPHILS; FEMALE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; IMMUNOGLOBULIN E; JOB SYNDROME; LEUKOCYTE COUNT; MALE; MIDDLE AGED; STAT3 TRANSCRIPTION FACTOR; SURVEYS AND QUESTIONNAIRES; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY; YOUNG ADULT;

EID: 85027344086     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-017-0429-z     Document Type: Article

References (33)

1. Grimbacher B, et al. Hyper-IgE syndrome with recurrent infections—an autosomal dominant multisystem disorder. N Engl J Med. 1999;340(9):692–702.
2. Freeman AF, Holland SM. Clinical manifestations of hyper IgE syndromes. Dis Markers. 2010;29(3–4):123–30.
3. Buckley RH, Wray BB, Belmaker EZ. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics. 1972;49(1):59–70.
4. Solomon JA, Abrams L, Lichtenstein GR. GI manifestations of Ehlers-Danlos syndrome. Am J Gastroenterol. 1996;91(11):2282–8.
5. Butterworth SA, Webber EM. Meconium thorax: a case of Bochdalek hernia and cecal perforation in a neonate with Job's syndrome. J Pediatr Surg. 2002;37(4):673–4.
6. Chen CM, et al. Colon perforation in a patient with hyperimmunoglobulin E (Job's) syndrome. J Pediatr Surg. 1995;30(10):1479–80.
7. Jacobs DH, et al. Esophageal cryptococcosis in a patient with the hyperimmunoglobulin E-recurrent infection (Job’s) syndrome. Gastroenterology. 1984;87(1):201–3.
8. Levy DE, Loomis CA. STAT3 signaling and the hyper-IgE syndrome. N Engl J Med. 2007;357(16):1655–8.
9. Milner JD, Sandler NG, Douek DC. Th17 cells, Job’s syndrome and HIV: opportunities for bacterial and fungal infections. Curr Opin HIV AIDS. 2010;5(2):179–83.
10. Milner JD, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature. 2008;452(7188):773–6.
11. Wilkins T, et al. The prevalence of dysphagia in primary care patients: a HamesNet Research Network study. J Am Board Fam Med. 2007;20(2):144–50.
12. Steiner SJ, et al. Ileocecal histoplasmosis simulating Crohn disease in a patient with hyperimmunoglobulin E syndrome. Pediatr Infect Dis J. 2009;28(8):744–6.
13. Gotzberger M, et al. A rare cause of gastrointestinal bleeding in a patient with hyper-IgE syndrome. Gut. 2004;53(10):1430–6.
14. Watanabe T, et al. Pancreatitis and cholangitis due to cytomegalovirus in a patient with hyperimmunoglobulin E syndrome. Pancreas. 2010;39(6):940–2.
15. Chandesris MO, et al. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine (Baltimore). 2012;91(4):e1–19.
16. Hwang EH, et al. Colon perforation in hyperimmunoglobulin E syndrome. J Pediatr Surg. 1998;33(9):1420–2.
17. Stover DG, et al. Diverticulitis in a young man with hyper-IgE syndrome. South Med J. 2010;103(12):1261–3.
18. Liacouras CA. Eosinophilic esophagitis. Gastroenterol Clin N Am. 2008;37(4):989–98. xi
19. Dellon ES, et al. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108(5):679–92. quiz 693
20. Siegel AM, Stone KD, Cruse G, Lawrence MG, Olivera A, Jung MY, et al. Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation. J Allergy Clin Immunol. 2013 Dec;132(6):1388–96.
21. Camilleri M, et al. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol. 2005;3(6):543–52.
22. Minegishi Y, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity. 2006;25(5):745–55.
23. Renner ED, et al. STAT3 mutation in the original patient with Job’s syndrome. N Engl J Med. 2007;357(16):1667–8.
24. Sperry SL, Crockett SD, Miller CB, Shaheen NJ, Dellon ES. Esophageal foreign-body impactions: epidemiology, time trends, and the impact of the increasing prevalence of eosinophilic esophagitis. Gastrointest Endosc. 2011;74(5):985–91.
25. Lagente V, Boichot E. Role of matrix metalloproteinases in the inflammatory process of respiratory diseases. J Mol Cell Cardiol. 2010;48(3):440–4.
26. Lopez-Otin C, Palavalli LH, Samuels Y. Protective roles of matrix metalloproteinases: from mouse models to human cancer. Cell Cycle. 2009;8(22):3657–62.
27. Sekhsaria V, et al. Plasma metalloproteinase levels are dysregulated in signal transducer and activator of transcription 3 mutated hyper-IgE syndrome. J Allergy Clin Immunol. 2011;128(5):1124–7.
28. Pickert G, et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med. 2009;206(7):1465–72.
29. Agarwal S, Mayer L. Gastrointestinal manifestations in primary immune disorders. Inflamm Bowel Dis. 2010;16(4):703–11.
30. Glocker EO, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009;361(21):2033–45.
31. Welte T, et al. STAT3 deletion during hematopoiesis causes Crohn’s disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc Natl Acad Sci U S A. 2003;100(4):1879–84.
32. Corley DA, et al. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. Gastroenterology. 2010;139(1):93–101.
33. Byrne KR, Panagiotakis PH, Hilden K, Thomas KL, Peterson KA, Fang JC. Retrospective analysis of esophageal food impaction: differences in etiology by age and gender. Dig Dis Sci. 2007;52(3):717–21.